Trial Profile
Effects of AV 608 on anxiety symptoms and pain rating and brain responses to experimental visceral pain in female patients with irritable bowel syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2012
Price :
$35
*
At a glance
- Drugs AV 608 (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- 03 Jan 2012 Results published in Alimentary Pharmacology and Therapeutics.
- 05 Nov 2010 New trial record.